GSK — GLAXOSMITHKLINE PLC

Ownership history in Bison Wealth, LLC  ·  38 quarters on record

This page tracks every 13F SEC filing in which Bison Wealth, LLC reported a position in GLAXOSMITHKLINE PLC (GSK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.5% (2015 Q1)
Avg. % of fund
0.24%
First filed
2015 Q1
Last filed
2024 Q3
Quarters held
38
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q3 ADDED 11,381 +151 +1.3% 0.07% $465K $38.44
2024 Q2 UNCHANGED 11,230 — 0% 0.08% $481K $35.87
2024 Q1 REDUCED 11,230 -14 -0.1% 0.08% $481K $39.61
2023 Q4 REDUCED 11,244 -817 -6.8% 0.07% $417K $33.91
34 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    GSK price (monthly, adj. close)

Other funds also holding GSK

As of 2025 Q4 — sorted by position size

Eversept Partners, LP 3Y 7Y 6.62% Mondrian Investment Partners LTD 3Y 7Y 4.7% EQUITY INVESTMENT CORP 3Y 7Y 4.07% Callodine Capital Management, LP 3Y 7Y 3.96% Hillman Capital Management, Inc. 3Y 7Y 3.53% KEATING INVESTMENT COUNSELORS INC 3Y 7Y 2.45% MILLER HOWARD INVESTMENTS INC /NY 3Y 7Y 2.43% Clean Yield Group 3Y 7Y 2.2% NIA IMPACT ADVISORS, LLC 3Y 2.08% Altrius Capital Management Inc 3Y 2.05%
← Back to Bison Wealth, LLC Holdings